BTG PACTUAL PARTICIPATIONS, LTD. ('Company'), pursuant to the provisions of CVM Instruction 358, announces to its shareholders and to the market in general that has signed a transaction involving Brasil Pharma S.A. ('Brasil Pharma'), under the terms described in the material fact hereby attached, also disclosed by Brasil Pharma on this date.
São Paulo, April 6, 2017.
BTG PACTUAL PARTICIPATIONS, LTD.
João Marcello Dantas Leite
Investor Relations Officer
To acess the PDF version, click here.
Investor Relations DepartmentEmail:ri@btgpactual.com
Phone: +55 (11) 3383-2000
Fax: +55 (11) 3383-2001
BTG Pactual Participations Ltd. published this content on 06 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 07 April 2017 00:54:13 UTC.
Original documenthttp://ir.btgpactual.com/btgpactual/web/conteudo_en.asp?idioma=1&tipo=40222&conta=44&id=240694
Public permalinkhttp://www.publicnow.com/view/4FB9494A93DAE1304EE31F14057A8DDB3D1AD6D2